T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor Read more about T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally Read more about T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. Read more about T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens Read more about T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 Read more about T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
T2 Biosystems to Host Business Update Call on October 10, 2024 Read more about T2 Biosystems to Host Business Update Call on October 10, 2024
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform Read more about T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens Read more about T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture Read more about T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union Read more about T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
